|
Aptamer Group PLC on Tuesday expressed optimism for the future tied to commercial relationships, financial strength and an expanding pipeline, as it posted a narrowed full-year loss. The York, England-based synthetic binders developer reported a pretax loss of £2.6 million for the financial year that ended June 30, narrowing from £3.1 million a year prior. Driving the improved bottom line was a mix of top-line gains and lower costs. Revenue advanced 40% to £1.2 million from £860,000, which Aptamer said reflects ‘accelerating commercial traction’. The company noted repeat business with ‘multiple top 20 pharmaceutical companies’. Further supporting the bottom line, administrative expenses fell 7.5% to £2.9 million from £3.2 million, owing to ‘continued cost discipline’. More specifically, employee costs reduced to £1.9 million from £2.1 million, and Aptamer reported a ‘slight decrease’ in its operational footprint. Looking ahead, Aptamer said it enters the new financial year in a position to deliver sustained growth, owing to a combination of ‘accelerating commercial traction, a dramatically expanded licensing portfolio...and strengthened financial resources.’ In July, the company completed a £1.8 million fundraising. Shares in the company fell 11% to 0.88 pence on Tuesday afternoon in London. ‘This has been a year of significant strategic progress for Aptamer as we continued to expand the breadth and commercial reach of our Optimer platform. With a 40% increase in revenue and a growing base of repeat business from leading pharmaceutical partners. Our technology is gaining strong traction across life sciences and adjacent markets,’ said Chief Executive Arron Tolley. ‘Looking ahead, the successful £1.8 million fundraising completed after year-end provides the resources to accelerate our growth strategy, strengthen in-house manufacturing, and advance high-value Optimer programmes. With an expanding pipeline, deepening commercial relationships, and a robust financial position, we are well-placed to deliver long-term value for our shareholders,’ continued Tolley. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
